Vienna Biocenter (VBC)

The Vienna BioCenter is a leading life sciences location, offering a unique combination of research, education, and companies on a single campus.

The Vienna BioCenter is one of Europe’s biggest life sciences hubs with over 1,800 employees from 70 different countries. Its research institutes and biotech companies are among the world leaders in their fields.

Since 1988, the Vienna BioCenter has been developing into one of the most outstanding and prominent life sciences hubs, not only in Austria but also in the Central European Region. With the founding of the Research Institute of Molecular Pathology (IMP) in 1985, the nucleus for the Vienna BioCenter was established. Very quickly, a University building went up next door and five departments were relocated there. In 1998, Vienna BioCenter spin-off company Intercell (now Valneva) was founded. Subsequently, the Austrian Academy of Sciences founded two new research institutes, IMBA and GMI, situated next to the IMP.

The Vienna BioCenter has continued to rapidly develop and now includes more than 30 complementary players in the life sciences. Since access to state-of-the-art infrastructure has become an important and decisive element for cutting-edge research, the Vienna BioCenter developed a vision for communal use of infrastructure. As a result, in 2010, the new Vienna BioCenter Core Facilities GmbH (VBCF), with a comprehensive range of new technologies, was set up with substantial financial support from the Austrian Ministry of Science and Research and the City of Vienna.

The Vienna BioCenter continues the Viennese tradition of diversity and will strive to continue its impressive development by building on its most prized assets: the ingenuity of its people, by providing them with an attractive work place.

Scientists, students, and entrepreneurs come together at the Vienna BioCenter to create a highly dynamic environment with internationally competitive standards.

The Vienna BioCenter is always on the lookout for the best talent.